Empowered Funds’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.64M Buy
+39,087
New +$3.46M 0.02% 778
2025
Q4
Sell
-4,820
Closed -$471K 1003
2025
Q3
$471K Buy
4,820
+1,106
+30% +$89.1K ﹤0.01% 1427
2025
Q2
$259K Buy
+3,714
New +$212K ﹤0.01% 1563
2025
Q1
Sell
-6,655
Closed -$465K 1617
2024
Q4
$465K Buy
+6,655
New +$553K 0.01% 1210
2024
Q1
Sell
-1,777
Closed -$230K 1373
2023
Q4
$230K Sell
1,777
-18,693
-91% -$2.58M 0.01% 1180
2023
Q3
$3.34M Buy
20,470
+19,061
+1,353% +$3.35M 0.1% 276
2023
Q2
$258K Buy
+1,409
New +$203K 0.01% 1005

Other funds holding ACLS

Empowered Funds's ACLS Position: Q1 2026 in Review

Empowered Funds opened a new position in Axcelis (ACLS) in Q1 2026: 39,087 shares worth $3.64M. The stake represents 0.02% of the portfolio and ranks #778 among its holdings. This is a return to the name: Empowered Funds previously reported a position in ACLS as recently as Q3 2025.

Empowered Funds first reported a position in ACLS in Q2 2023 and has held it in 7 quarters since. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Empowered Funds held 39,087 shares of Axcelis worth $3.64M as of Q1 2026.
  • Axcelis was a new Empowered Funds position in Q1 2026.
  • Axcelis made up 0.02% of Empowered Funds's portfolio in Q1 2026, its #778 holding.
  • Empowered Funds first reported a position in Axcelis in Q2 2023 and has held it in 7 quarters since.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.